Tonix Pharmaceuticals (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to prevent and treat central nervous system disorders, immunology conditions and rare diseases, and vaccines to prevent infectious diseases.